These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1091127)

  • 21. Strategy, yield and risks of controlling plasma lipids in the primary prevention of coronary heart disease.
    Oliver MF
    Adv Exp Med Biol; 1985; 183():225-40. PubMed ID: 3898747
    [No Abstract]   [Full Text] [Related]  

  • 22. Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials.
    Dewar HA; Oliver MF
    Br Med J; 1971 Dec; 4(5790):784-6. PubMed ID: 4943607
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease.
    Steele P; Battock D; Genton E
    Circulation; 1975 Sep; 52(3):473-6. PubMed ID: 1157247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary prevention of coronary heart disease by lowering lipids: results and implications.
    Levy RI
    Am Heart J; 1985 Nov; 110(5):1116-22. PubMed ID: 3904377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of long-term administration of clofibrate on the composition of blood lipids in patients with atherosclerosis.
    Poleszak J; Korolko A
    Pol Med J; 1972; 11(2):250-6. PubMed ID: 5071512
    [No Abstract]   [Full Text] [Related]  

  • 26. The influence of Clofibrat on plasma lipid levels.
    Szostak WB; Cybulska B; Ruzyllo E
    Mater Med Pol; 1971; 3(4):12-4. PubMed ID: 5162168
    [No Abstract]   [Full Text] [Related]  

  • 27. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER; Sutherland WH; Temple Wa
    N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diurnal lipid and lipoprotein profiles with bezafibrate and clofibrate in healthy volunteers.
    Oster P; Schlierf G; Lang PD; Mordasini R; Vollmar J
    Pharmatherapeutica; 1985; 4(5):267-77. PubMed ID: 4070320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
    Kaffarnik H; Schneider J; Haase W
    Dtsch Med Wochenschr; 1975 Nov; 100(48):2486-8. PubMed ID: 1104303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of clofibrate and a fat-modified diet on serum lipids.
    Brown HB; Lewis LA; Page IH
    Clin Pharmacol Ther; 1975 Feb; 17(2):171-8. PubMed ID: 164312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors related to progressive narrowing in aortocoronary vein grafts studied 1 and 5 years after surgery.
    Palac RT; Meadows WR; Hwang MH; Loeb HS; Pifarre R; Gunnar RM
    Circulation; 1982 Aug; 66(2 Pt 2):I40-4. PubMed ID: 6979440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the effectiveness of the treatment of arteriosclerosis].
    Bobkova VI; Mazurova SV; Fomchenkov SI
    Kardiologiia; 1974 Jul; 14(7):108-13. PubMed ID: 4431129
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of clofibrate on plasma lipids and high-density lipoprotein levels in renal allograft recipients.
    Bagdade JD; Shantharam VV; Sollek M; Albers JJ
    Clin Nephrol; 1979 Aug; 12(2):83-6. PubMed ID: 230927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clofibrate: a final verdict?
    Lancet; 1978 Nov; 2(8100):1131-2. PubMed ID: 82687
    [No Abstract]   [Full Text] [Related]  

  • 35. A long-time study of the blood lipids of two students of atherosclerosis.
    Page IH; Lewis LA
    Circulation; 1969 Dec; 40(6):915-8. PubMed ID: 5387364
    [No Abstract]   [Full Text] [Related]  

  • 36. The treatment of cerebrovascular disease with clofibrate. Final report of the Veterans Administration Cooperative Study of Atherosclerosis, Neurology Section.
    Stroke; 1973; 4(4):684-93. PubMed ID: 4723698
    [No Abstract]   [Full Text] [Related]  

  • 37. W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators.
    Lancet; 1980 Aug; 2(8191):379-85. PubMed ID: 6105515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Fabbrocini V
    Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692
    [No Abstract]   [Full Text] [Related]  

  • 39. The clofibrate trial--the lipid hypothesis retested.
    Med J Aust; 1979 Jun; 1(11):490-1. PubMed ID: 381862
    [No Abstract]   [Full Text] [Related]  

  • 40. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.